HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study.

Abstract
Plasma soluble Receptor for Advanced Glycation End-products (sRAGE) is a strong marker of vascular outcomes although evidence on the direction of association is mixed. Compared to whites, blacks have lower levels of sRAGE. We hypothesized that genetic determinants of sRAGE would help clarify the causal role of sRAGE and the black-white difference in sRAGE levels. We conducted a genome-wide analysis of sRAGE in whites and blacks from the Atherosclerosis Risk in Communities Study. Median plasma sRAGE levels were lower in blacks than whites (728 vs. 1067 pg/ml; P<0.0001). The T (vs. C) allele of rs2070600, a missense variant in AGER, the gene encoding RAGE, was associated with approximately 50% lower sRAGE levels in both whites (N = 1,737; P = 7.26x10-16; minor allele frequency (MAF) = 0.04) and blacks (N = 581; P = 0.02; MAF = 0.01). In blacks, the T (vs. C) allele of rs2071288, intronic to AGER, was associated with 43% lower sRAGE levels (P = 2.22x10-8; MAF = 0.10) and was nearly absent in whites. These AGER SNPs explained 21.5% and 26% of the variation in sRAGE in blacks and whites, respectively, but did not explain the black-white difference in sRAGE. These SNPs were not significantly associated with incident death, coronary heart disease, diabetes, heart failure, or chronic kidney disease in whites (N = 8,130-9,017) or blacks (N = 2,293-2,871) (median follow up ~20 years). We identified strong genetic determinants of sRAGE that did not explain the large black-white difference in sRAGE levels or clearly influence risk of clinical outcomes, suggesting that sRAGE may not be a causal factor in development of these outcomes.
AuthorsNisa M Maruthur, Man Li, Marc K Halushka, Brad C Astor, James S Pankow, Eric Boerwinkle, Josef Coresh, Elizabeth Selvin, Wen Hong Linda Kao
JournalPloS one (PLoS One) Vol. 10 Issue 6 Pg. e0128452 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26083729 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Receptor for Advanced Glycation End Products
Topics
  • Black or African American (genetics)
  • Alleles
  • Cardiovascular Diseases (etiology, genetics, mortality)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Gene Frequency
  • Genome-Wide Association Study
  • Humans
  • Male
  • Metagenomics
  • Middle Aged
  • Mutation, Missense
  • Polymorphism, Single Nucleotide
  • Receptor for Advanced Glycation End Products (blood, genetics)
  • Risk Factors
  • Survival Analysis
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: